As clinical trials become more demanding, evidence must be quantitative, reproducible, and easily communicateable. Whether it’s demonstrating skin tone evenness, hair regrowth, or reduced oil production, brands like CROs need imaging tools that bridge the gap between science and communication.
Pixience will participate in the HPCI India 2026 to present the C-Cube 3 Clinical Research, a high-performance imager designed to meet the current expectations of the cosmetics market: speed, standardization, solid evidence and high-definition visualization.
Unique on the market, the C-Cube combines in a single compact device:
- High-resolution microdermoscopic imaging,
- Metric and colorimetric calibration,
- Automated analysis,
- 2D and 3D acquisitions for in vivo and ex vivo studies.
It can be used to quantify a wide variety of parameters: pigmentation, erythema, roughness (ISO 25178), follicular density, hair diameter, desquamation, and many others.
The C-Cube is also a powerful tool for underpinning a wide range of cosmetic claims. It translates clinical changes into quantitative and visual indicators.
This versatility makes it an ideal tool for supporting many cosmetic claims:
- Skin texture : 3D measurement of roughness (Sa, Sq, Sdr).
- Soothing : an indication of erythema, even on the scalp.
- Haircare : automatic diameter analysis and vellus/terminal classification.
All of this can be exported in the form of high-definition visuals that facilitate scientific and marketing communication.
The diversity of measurable parameters makes it possible to address a wide variety of product claims, whether they are skin or capillary.
These features make it easy to align scientific rigor and marketing narrative, all in exportable high-definition visuals.
In a context where speed of execution, traceability and credibility are essential, the C-Cube optimizes every step of the studies: faster protocols, less manual post-processing, reliable and immediately actionable results.
Pixience looks forward to meeting with evaluation experts and innovation leaders at HPCI India 2026 to explore how imaging can open up new perspectives in the validation of cosmetic claims.
Contact
MANGERUCA Sébastien – CEO
sales@pixience.com
